Abstract Individuals infected with HIV are living longer due to effective treatment with combination antiretroviral therapy (cART). Despite these advances, HIV-associated neurocognitive disorders (HAND) remain prevalent. In this study, we analyzed resting state functional connectivity (rsfc) data from HIV-infected and matched HIV-uninfected adults aged 60 years and older to determine associations between HIV status, neuropsychological performance, and clinical variables. HIV-infected participants with detectable plasma HIV RNA exhibited decreased rs-fc within the salience (SAL) network compared to HIV-infected participants with suppressed plasma HIV RNA. We did not identify differences in rs-fc within HIV-infected individuals by HAND status. Our analysis identifies focal deficits in the SAL network that may be mitigated with suppression of plasma virus. However, these findings suggest that rs-fc may not be sensitive as a marker of HAND among individuals with suppressed plasma viral loads.
Introduction
Older individuals make up an increasing portion of the HIV-infected population. Currently, about half of all HIV-infected individuals in the USA are 50 years of age and older. This population represents a group of individuals with unique aspects of disease course and complications (Brooks et al. 2012) . The expansion of this older demographic is, in large part, due to combination antiretroviral therapy (cART) that has increased life expectancy. There are few data on individuals over age 60 years, yet elucidating the effects of HIV on brain function in this unique population is particularly important due to the increased risk of neurodegenerative disorders at older ages. Moreover, evidence suggests that HIV and its treatments may exacerbate normal age-related health concerns, and this oldest group has both extended duration of HIV and longer exposure to antiretroviral treatments (High et al. 2012) . It remains unclear whether HIV has an additive or even accelerative effect on the aging process (Pathai et al. 2014) .
HIV infection can be accompanied by cognitive deterioration, known as HIV-associated neurocognitive disorders (HAND) in 30-50 % of individuals (Heaton et al. 2011) . The frequency of cognitive dysfunction and its impact on everyday function increases with age (Vance et al. 2013) . The virus enters the brain soon after infection, causing dysfunction as measured by cerebrospinal fluid (CSF) cytokines and magnetic resonance spectroscopy (MRS) . While cART has decreased the incidence of the severe form of HAND (e.g., HIV-associated dementia (HAD)), less severe manifestations of cognitive dysfunction persist (Heaton et al. 2011) .
Both aging and HIV infection have a negative impact on overall neuropsychological (NP) and everyday functional performance (Glisky 2007; Woods et al. 2009 ). In particular, HIV-uninfected older compared to younger individuals exhibit decreased performance on measures of memory, executive function, processing speed, and motor function (Hedden et al. 2012) . Similarly, older HIV-infected individuals tend to exhibit greater deficits in multiple cognitive domains, particularly executive functioning ). Older HIVinfected individuals also have greater declines in daily functioning measures (e.g., instrumental and basic activities of daily living) (Morgan et al. 2012) .
Current methods that use NP testing to establish HAND may miss subtle changes in brain function seen in older HIV-infected individuals. Observed changes in NP performance may reflect a combination of factors including HIV effects, side effects of cART, or low-level inflammation within the brain due to persistent viral reservoirs. Neuroimaging using techniques such as bloodoxygen-level-dependent (BOLD) functional magnetic resonance imaging (fMRI) has become a useful tool in the assessment of the neurophysiological effects of HIV and aging Thomas et al. 2015) . Spontaneous fluctuations in the BOLD signal unmask intrinsic brain network maps. Resting state functional connectivity (rs-fc) can be obtained without the participant performing a particular task and without use of contrast agents (Zhang and Raichle 2010) .
Recent imaging research identified changes in rs-fc due to age and various neurodegenerative diseases. Age is associated with a reduction of functional correlations within certain resting state networks (RSNs) (e.g., default mode network (DMN)) (Andrews-Hanna et al. 2007; Yao et al. 2013; Geerligs et al. 2014) . Selective brain vulnerability correlates with age-associated neurodegenerative disorders (Seeley et al. 2009 ). A resting state signature for HIV may exist. In past work, HIV infection was associated with abnormalities in distinct network cortical hubs while aging was associated with widespread decreases in rs-fc (Thomas et al. 2015) .
The assessment of HIV virologic and immunological status (e.g., plasma CD4 count, plasma HIV RNA), as they impact clinical outcomes, is well established. However, the relationship between such measures and brain function among individuals on cART remains less clear (Kaul 2009 ). As a non-invasive means to evaluate brain function, rs-fc could assist in more tailored medical management, especially among older HIV-infected patients where co-morbidities and polypharmacy are frequent (Nightingale et al. 2014) . In the present study, we combined NP testing and rs-fc to assess brain function within an older cohort of HIV-infected and HIV-uninfected adults (≥60 years old) to investigate relationships between measures of brain connectivity (rs-fc), cognition (NP testing), and clinical measures (including plasma HIV RNA).
Methods
Selection of participants HIV-infected participants (n=52) were enrolled in the UCSF HIV Over 60 Cohort, a study conducted at the University of California San Francisco (UCSF), to understand cognition in elder (≥60 years) HIVinfected individuals. All were recruited by community advertisements and physician referrals with no selection criteria related to cognitive symptoms. For the present study, we selected images from the first scanning session from all subjects who had completed neuroimaging using a Siemens 3T MRI. One participant was excluded due to preexisting white matter changes thought to be associated with chronic inflammatory demyelinating polyneuropathy (CIDP). Most HIV-infected participants (94 %) had been on stable cART for at least 12 months prior to neuroimaging.
Healthy HIV-uninfected volunteers (n = 29) had enrolled in studies conducted by the UCSF Memory and Aging Center. Individuals from these studies of normal controls were included in the present study if they were between 60 and 70 years old, free of other neurological disorders, and had normal neuropsychological testing performance with no symptoms, as determined by a consensus conference including a behavioral neurologist. We initially selected only male control participants between 60 and 70 years of age and then supplemented this group with 1:1 random sampling of women to match the HIVinfected group by gender. Healthy HIV-uninfected participants underwent the same neuroimaging protocols on the same MRI scanner as HIV-infected participants. All participants signed informed consent forms approved by the UCSF Committee on Human Research.
Cognitive and clinical characterization All participants completed a 90-min cognitive battery, as previously described (Chiao et al. 2013) . The NP battery assessed the following domains: memory (delayed and immediate recalls of the California Verbal Learning Test II and Story Recall tasks, delayed recall of the Benson Figure Copy Modalities Test, and Stroop color naming). Individual tests were standardized to an age-and education-adjusted Z-score using published normative data. A composite domain score was calculated as the arithmetic mean of Z-scores from individual tests constituting each cognitive domain. A global neuropsychological score (NPZ-global) was calculated by averaging individual Z-scores across all tests. All participants underwent a comprehensive neurological examination, first symptoms questionnaire and, when possible, proxy informant interview to assess functional capabilities (47 of 52 HIVinfected participants).
HIV-infected participants additionally completed the Grooved Pegboard and Finger Tapping tests for dominant and non-dominant hands to conform with the 2007 BFrascati^HAND diagnostic criteria (Antinori et al. 2007) . HIV-infected participants with HAND were classified as having asymptomatic neurocognitive impairment (ANI), mild neurocognitive disorder (MND), or HIVassociated dementia (HAD) in a consensus conference that included at least one neuropsychologist and one behaviorally trained neurologist using clinical acumen and guided by Frascati criteria.
Clinical variables We used a structured physician interview that included questions about self-reported duration of infection, nadir CD4 cell count, antiretroviral history, opportunistic infections, and other important medical history variables. We measured plasma HIV RNA and CD4 cell count if not available from clinical records within 3 months of the study visit. HIV-infected subjects with no recent laboratory data available were excluded from analyses examining effects of viral load (2 of 52 HIV-infected individuals).
Image acquisition, preprocessing, and quality assurance Participants were scanned using a 3T Siemens Tim Trio with a 12-channel head coil. Structural magnetic resonance imaging scans were obtained with T1-weighted magnetization-prepared rapid acquisition gradient-echo (MPRAGE) sequences (matrix: 1.0×1.0×1.0 mm 3 , repetition time (TR)=2300 ms, echo time (TE)=2.98 ms, flip angle (FA)=9°, inversion time= 900 ms). rs-fc scans were collected using a gradient spin-echo sequence (voxel size=2.5×2.5×3.0 mm 3 , TR=2000 ms, TE= 27 ms, FA=80°, field of view (FoV)=230 mm) that was sensitive to blood-oxygen-level-dependent (BOLD) contrast. A total of 36 3.0-mm thick slices were acquired parallel to the anterior commissure/posterior commissure plane. A single rs-fc scan (240 volumes) was acquired for each participant.
The preprocessing of rs-fc data followed conventional methods, as previously described (Shulman et al. 2010; Brier et al. 2014) . Preprocessing included correction for slicedependent intensity differences (Hacker et al. 2013) , rigid body correction for head movement within and across runs, and atlas transformation. A frame censoring technique was performed to minimize motion-related BOLD signal changes (Smyser et al. 2010; Power et al. 2012) . Briefly, for each frame, we calculated a root mean square (RMS) of signal intensity change over the previous frame. Frames with large RMS signal intensity changes (>0.7 %) were removed. In order to facilitate a temporal filtering procedure, removed frames were replaced voxel by voxel with linearly interpolated values (Power et al. 2014) . The replaced frames were discarded after temporal filtering.
Additional preprocessing steps were carried out in preparation for the correlation analysis. First, several sources of spurious variance were removed from the data by linear regression: (1) six parameters generated from rigid body correction of head motion; (2) the whole brain signal averaged from a mask region in atlas space; and (3) signal from ventricles and deep cerebral white matter. Second, the residual BOLD time series underwent a temporal low-pass filtering (<0.1 Hz) and spatial smoothing with a 6-mm full width at half maximum Gaussian blur. Controversy remains concerning the inclusion of global signal regression (GSR) as it may differentially impact estimates of rs-fc across groups (Saad et al. 2013 ). To address this potential concern, we compared beta values from GSR for all primary comparisons: HIV-uninfected and HIVinfected individuals, among HIV-uninfected individuals vs. HIV-infected individuals with normal cognition vs. HIVinfected individuals with ANI or MND, and between individuals with detectable vs. undetectable plasma HIV RNA within the HIV-infected group. We found no group-wise differences in the beta values from GSR for any of these comparisons (all p≥0.05).
We applied the previously described quality assurance criteria that excluded an individual's data set with RMS from BOLD signal variance (across all frames) >2.5 % or head motion exceeding 1.25 mm (Wang et al. 2012 ). In addition, any individual with more than 40 % of frames removed was excluded from subsequent analyses (Brier et al. 2014) . However, we found that all individuals met quality assurance measures and none were excluded. The number of removed frames was not different by any of the primary comparison groups described above (all p≥0.09).
Participant-level analysis of rs-fc within RSNs For each participant, a cross-correlation matrix was constructed from the time series derived from 36 regions of interest (ROIs) that included 5 RSNs (DMN, dorsal attention (DAN), control (CON), salience (SAL), and sensorimotor (SMN) networks). The cross-correlation matrices were averaged separately across HIV-infected and HIV-uninfected individuals. For each RSN, a composite score was calculated by averaging Fisher's Z-transformed correlation coefficients across all ROI pairs included within a particular RSN to reduce the dimensionality of the statistical analysis ).
Statistical analysis Demographic variables and NP test scores
were compared between HIV-infected and HIV-uninfected individuals using t tests. Treating composite scores of each RSN as a dependent variable, the effects of HIV (HIV-infected vs. HIV-uninfected) and HAND (HIV-uninfected vs. HIVinfected with no cognitive impairment vs. HIV-infected with ANI or MND) were analyzed separately using multivariate analyses of variance. Similarly, the effect of plasma HIV RNA detectability on RSN composite scores was examined within HIV-infected participants using multivariate analyses of variance. We used multivariate linear regression to test the effects of current and nadir CD4 cell counts on RSN composite scores. The relationships between RSN composite scores and NP performance were investigated separately within HIV-infected and HIV-uninfected individuals using Pearson correlations with a false discovery rate of p<0.05 after correction for multiple comparisons.
Results
Participant demographics The final sample included 52 HIV-infected and 29 HIV-uninfected participants (Table 1) . By design, the HIV-infected and HIV-uninfected groups did not differ by gender, but the HIV-uninfected cohort was slightly older and reported a greater number of years of education. All HIV-infected participants that met HAND criteria (n=27) were classified as having ANI or MND, with no cases of HAD. Significant differences were observed between HIVinfected and HIV-uninfected groups for each of the NPZdomain scores and for the NPZ-global score.
Effects of HIV on RSNs
We examined five RSN composite scores and noted no significant differences between HIVinfected and HIV-uninfected groups (Fig. 1) . The withinnetwork (intra-network) correlations are shown in blocks along the diagonal while between-network (inter-network) correlations are shown in off-diagonal blocks. The computed matrices revealed only subtle differences in inter-and intranetwork correlations between the two groups. Both matrices showed positive correlations within networks and negative correlations between networks.
Correlations between HAND and RSN composite scores The ANI and MND groups were combined into a HAND group and compared to HIV-infected participants without HAND. No relationship was observed by HAND status on RSN composite scores (Fig. 2) . We also studied the relationship between NPZ-domain scores and RSN composite scores. Among HIV-uninfected controls, no correlations between NP test scores and rs-fc were found for any RSN. For the HIVinfected participants, a correlation between psychomotor function and SAL composite score (r=0.293, uncorrected p=0.035) was observed. However, this finding was not significant after correction for multiple comparisons.
Relationship between RSN composite scores and clinical variables Within the HIV-infected group, 50/52 cases had plasma HIV RNA measured, among which 35 were undetectable (≤75 copies/mL) and 15 were detectable and had a mean (SD) log 10 HIV RNA of 2.04 (0.83). We found a reduction in SAL composite scores for the HIV-infected group with detectable compared to undetectable plasma HIV RNA (p=0.011, Fig. 3) . A subsequent Pearson correlation revealed no significant correlation between the SAL composite score and plasma HIV RNA value (r = −0.253, p = 0.363) among HIVinfected individuals with detectable HIV RNA; however, most detectable cases had very low levels. Similar analyses to investigate the effects of current and nadir CD4 cell count on rsfc did not identify significant associations. A comparison of rs-fc data from HIV-infected individuals with detectable HIV RNA to HIV-uninfected controls yielded no significant differences for any RSN.
Discussion
This work investigated rs-fc and NP performance in HIVinfected and uninfected individuals over 60 years old. HIVinfected individuals with detectable plasma HIV RNA had decreased rs-fc within the SAL compared to those with undetectable plasma HIV RNA. However, no relationship was found between domain-specific NP performance (memory, executive, attention, visuospatial, psychomotor) and rs-fc in the 5 RSNs (DMN, DAN, CON, SAL, SMN) . We also found no effects of HAND diagnosis on rs-fc.
The relationship between rs-fc in the SAL network and detectability of plasma HIV RNA suggests that the virus may selectively affect distinct RSNs and raises the question of whether the virus or inflammatory pathways may alter rs-fc in the SAL, a network that provides emotional stimuli to neural systems (Seeley et al. 2009 ). Dysfunction in this network may explain the deficits in emotional conflict processing seen in HIV-infected individuals (Schulte et al. 2011) .
Previous research has focused on HIV RNA as a biomarker for cognitive dysfunction. However, with increased efficacy of cART, many HIV-infected individuals with HAND are virologically suppressed; thus, the relationship between plasma HIV RNA and cognition has become less important in the current cART era (Clifford and Ances 2013; Nightingale et al. 2014) . Cerebrospinal fluid (CSF) rather than plasma HIV RNA may be more predictive of cognitive impairment; however, detectable CSF HIV RNA by standard assays and in the absence of detectable plasma HIV RNA (BCNS escape^) is rare (Eden et al. 2010) . Future research comparing CSF HIV viral load with rs-fc may shed light on this issue, particularly in studies that have the capability of measuring single-copy levels of CSF HIV RNA.
Of special interest is the lack of difference in rs-fc by HIV status. All HIV-infected individuals were receiving cART. The group's median duration of HIV infection exceeded two decades; thus, survivorship tendencies could exist. This survivorship bias could contribute to a negative finding. It was only when we evaluated HIV-infected individuals with detectable viral loads that we observed differences within the HIVinfected group. This suggests that cART restores networks within HIV-infected individuals once suppression of HIV RNA is achieved, such that these individuals are similar to HIV-uninfected controls. Our findings are in agreement with a past publication noting no differences in neural integrity using diffusor tensor imaging (DTI) in HIV-infected individuals after they received cART (Wright et al. 2012) . However, our current findings are in contrast with recent publications evaluating the same participants enrolled in the current study that observed broad DTI and DTI connectivity differences by HIV status (Jahanshad et al. 2012; Nir et al. 2013 ). Thus, it remains less clear which modality may be most sensitive to HIV effects in the era of cART. Longitudinal studies using multiple neuroimaging modalities and particularly among participants before and after cART would be helpful. Our findings are unique in that we examined an elder cohort of participants with well-controlled HIV. Individuals in our study were often highly educated and primarily male, further limiting generalizability to more diverse populations. As is now common among patients with access to cART, HIV- infected individuals in our study had less severe cognitive impairment and no subject met criteria for HAD. It would be of interest to expand the present cohort to include HIVinfected individuals with a wider range of HAND severity. In the current study, even after applying rather stringent criteria to control for excess movement, relatively few individuals were removed with missing data interpolated, strengthening our approach.
In sum, we observed a loss in rs-fc within the SAL network of older HIV-infected individuals with a detectable compared to undetectable plasma HIV RNA. The combination of HIV infection and advanced age might influence activity within certain functionally defined RSNs. The present work suggests that rs-fc may be able to detect changes in brain function as a result of uncontrolled HIV RNA but may be a less robust measure among those with suppressed virus or to distinguish HAND from non-HAND in a treated population.
